China Injectable Anticoagulants Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Injectable Anticoagulants Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Injectable Anticoagulants Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Injectable Anticoagulants Overall Market Size
2.1 China Injectable Anticoagulants Market Size: 2021 VS 2027
2.2 China Injectable Anticoagulants Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Injectable Anticoagulants Players in China Market
3.2 Top China Injectable Anticoagulants Companies Ranked by Revenue
3.3 China Injectable Anticoagulants Revenue by Companies
3.4 Top 3 and Top 5 Injectable Anticoagulants Companies in China Market, by Revenue in 2020
3.5 Companies Injectable Anticoagulants Product Type
3.6 Tier 1, Tier 2 and Tier 3 Injectable Anticoagulants Players in China Market
3.6.1 List of Tier 1 Injectable Anticoagulants Companies in China
3.6.2 List of Tier 2 and Tier 3 Injectable Anticoagulants Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Injectable Anticoagulants Market Size Markets, 2021 & 2027
4.1.2 Low-Molecular-Weight Heparin (LMWH)
4.1.3 Direct Thrombin Inhibitor (DTI)
4.1.4 Others
4.2 By Type - China Injectable Anticoagulants Revenue & Forecasts
4.2.1 By Type - China Injectable Anticoagulants Revenue, 2016-2021
4.2.2 By Type - China Injectable Anticoagulants Revenue, 2022-2027
4.2.3 By Type - China Injectable Anticoagulants Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Injectable Anticoagulants Market Size, 2021 & 2027
5.1.2 VTE
5.1.3 ACS/MI
5.1.4 AF
5.1.5 Others
5.2 By Application - China Injectable Anticoagulants Revenue & Forecasts
5.2.1 By Application - China Injectable Anticoagulants Revenue, 2016-2021
5.2.2 By Application - China Injectable Anticoagulants Revenue, 2022-2027
5.2.3 By Application - China Injectable Anticoagulants Revenue Market Share, 2016-2027
6 Injectable Anticoagulants Companies Profiles
6.1 Sanofi
6.1.1 Sanofi Company Details
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Injectable Anticoagulants Introduction
6.1.4 Sanofi Injectable Anticoagulants Revenue in China Market (2016-2021)
6.1.5 Sanofi Recent Developments
6.2 Genentech (Roche)
6.2.1 Genentech (Roche) Company Details
6.2.2 Genentech (Roche) Business Overview
6.2.3 Genentech (Roche) Injectable Anticoagulants Introduction
6.2.4 Genentech (Roche) Injectable Anticoagulants Revenue in China Market (2016-2021)
6.2.5 Genentech (Roche) Recent Developments
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Details
6.3.2 Boehringer Ingelheim Business Overview
6.3.3 Boehringer Ingelheim Injectable Anticoagulants Introduction
6.3.4 Boehringer Ingelheim Injectable Anticoagulants Revenue in China Market (2016-2021)
6.3.5 Boehringer Ingelheim Recent Developments
6.4 Pfizer
6.4.1 Pfizer Company Details
6.4.2 Pfizer Business Overview
6.4.3 Pfizer Injectable Anticoagulants Introduction
6.4.4 Pfizer Injectable Anticoagulants Revenue in China Market (2016-2021)
6.4.5 Pfizer Recent Developments
6.5 The Medicines Company
6.5.1 The Medicines Company Company Details
6.5.2 The Medicines Company Business Overview
6.5.3 The Medicines Company Injectable Anticoagulants Introduction
6.5.4 The Medicines Company Injectable Anticoagulants Revenue in China Market (2016-2021)
6.5.5 The Medicines Company Recent Developments
6.6 Aspen
6.6.1 Aspen Company Details
6.6.2 Aspen Business Overview
6.6.3 Aspen Injectable Anticoagulants Introduction
6.6.4 Aspen Injectable Anticoagulants Revenue in China Market (2016-2021)
6.6.5 Aspen Recent Developments
6.7 Otsuka
6.7.1 Otsuka Company Details
6.7.2 Otsuka Business Overview
6.7.3 Otsuka Injectable Anticoagulants Introduction
6.7.4 Otsuka Injectable Anticoagulants Revenue in China Market (2016-2021)
6.7.5 Otsuka Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Injectable Anticoagulants Market Opportunities & Trends in China Market
Table 2. Injectable Anticoagulants Market Drivers in China Market
Table 3. Injectable Anticoagulants Market Restraints in China Market
Table 4. Key Players of Injectable Anticoagulants in China Market
Table 5. Top Injectable Anticoagulants Players in China Market, Ranking by Revenue (2019)
Table 6. China Injectable Anticoagulants Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Injectable Anticoagulants Revenue Share by Companies, 2016-2021
Table 8. Companies Injectable Anticoagulants Product Type
Table 9. List of Tier 1 Injectable Anticoagulants Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Injectable Anticoagulants Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Injectable Anticoagulants Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Injectable Anticoagulants Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Injectable Anticoagulants Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Injectable Anticoagulants Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Injectable Anticoagulants Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Injectable Anticoagulants Revenue (US$, Mn), 2022-2027
Table 17. Sanofi Company Details
Table 18. Sanofi Business Overview
Table 19. Sanofi Injectable Anticoagulants Product
Table 20. Sanofi Injectable Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Sanofi Recent Developments
Table 22. Genentech (Roche) Company Details
Table 23. Genentech (Roche) Business Overview
Table 24. Genentech (Roche) Injectable Anticoagulants Product
Table 25. Genentech (Roche) Injectable Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Genentech (Roche) Recent Developments
Table 27. Boehringer Ingelheim Company Details
Table 28. Boehringer Ingelheim Business Overview
Table 29. Boehringer Ingelheim Injectable Anticoagulants Product
Table 30. Boehringer Ingelheim Injectable Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Boehringer Ingelheim Recent Developments
Table 32. Pfizer Company Details
Table 33. Pfizer Business Overview
Table 34. Pfizer Injectable Anticoagulants Product
Table 35. Pfizer Injectable Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Pfizer Recent Developments
Table 37. The Medicines Company Company Details
Table 38. The Medicines Company Business Overview
Table 39. The Medicines Company Injectable Anticoagulants Product
Table 40. The Medicines Company Injectable Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 41. The Medicines Company Recent Developments
Table 42. Aspen Company Details
Table 43. Aspen Business Overview
Table 44. Aspen Injectable Anticoagulants Product
Table 45. Aspen Injectable Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Aspen Recent Developments
Table 47. Otsuka Company Details
Table 48. Otsuka Business Overview
Table 49. Otsuka Injectable Anticoagulants Product
Table 50. Otsuka Injectable Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Otsuka Recent Developments
List of FiguresFigure 1. Injectable Anticoagulants Segment by Type
Figure 2. Injectable Anticoagulants Segment by Application
Figure 3. China Injectable Anticoagulants Market Overview: 2020
Figure 4. China Injectable Anticoagulants Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Injectable Anticoagulants Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Injectable Anticoagulants Revenue in 2020
Figure 7. By Type - China Injectable Anticoagulants Revenue Market Share, 2016-2027
Figure 8. By Application - China Injectable Anticoagulants Revenue Market Share, 2016-2027
Figure 9. Sanofi Injectable Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Genentech (Roche) Injectable Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Boehringer Ingelheim Injectable Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Pfizer Injectable Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. The Medicines Company Injectable Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Aspen Injectable Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Otsuka Injectable Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)